RPG Life Sciences Limited (NSE:RPGLIFE) — Stock Price
RPG Life Sciences Limited (NSE:RPGLIFE) is currently trading at Rs2638.00 INR, down 0.88% today. Over the past 52 weeks, shares have ranged between Rs1744.00 and Rs3017.10. This page tracks RPG Life Sciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of RPG Life Sciences Limited.
RPG Life Sciences Limited (RPGLIFE) Stock Price Chart — Daily History & Trading Volume
The chart below tracks RPG Life Sciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
RPG Life Sciences Limited Income Statement — Revenue, Profit & Earnings by Year
RPG Life Sciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | Rs7.08 Billion | Rs6.53 Billion | Rs5.77 Billion | Rs5.09 Billion | Rs4.37 Billion |
| Cost of Revenue | Rs4.15 Billion | Rs2.14 Billion | Rs3.71 Billion | Rs3.41 Billion | Rs1.50 Billion |
| Gross Profit | Rs2.92 Billion | Rs4.39 Billion | Rs3.93 Billion | Rs1.70 Billion | Rs2.87 Billion |
| Research & Development | — | Rs14.70 Million | Rs93.60 Million | Rs89.30 Million | Rs89.70 Million |
| SG&A | — | Rs1.27 Billion | Rs1.33 Billion | Rs1.18 Billion | Rs1.01 Billion |
| Total Operating Expenses | Rs1.67 Billion | Rs1.26 Billion | Rs972.30 Million | Rs822.20 Million | Rs2.15 Billion |
| Operating Income | Rs1.26 Billion | Rs3.13 Billion | Rs1.10 Billion | Rs874.70 Million | Rs707.40 Million |
| EBITDA | Rs1.47 Billion | Rs1.60 Billion | Rs1.36 Billion | Rs1.08 Billion | Rs902.40 Million |
| EBIT | Rs1.26 Billion | Rs1.38 Billion | Rs1.19 Billion | Rs928.30 Million | Rs745.80 Million |
| Interest Expense | Rs8.90 Million | Rs6.20 Million | Rs14.40 Million | Rs11.50 Million | Rs14.10 Million |
| Income Before Tax | Rs1.54 Billion | Rs2.33 Billion | Rs1.18 Billion | Rs916.80 Million | Rs731.70 Million |
| Income Tax Expense | Rs390.30 Million | Rs496.40 Million | Rs301.80 Million | Rs240.40 Million | Rs216.90 Million |
| Net Income | Rs1.15 Billion | Rs1.83 Billion | Rs876.60 Million | Rs676.40 Million | Rs514.80 Million |
RPG Life Sciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes RPG Life Sciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | Rs7.93 Billion | Rs6.58 Billion | Rs5.13 Billion | Rs4.19 Billion | Rs3.45 Billion |
| Total Current Assets | Rs5.59 Billion | Rs4.65 Billion | Rs2.98 Billion | Rs2.64 Billion | Rs2.07 Billion |
| Cash & Equivalents | — | Rs260.00 Million | Rs170.00 Million | Rs322.20 Million | — |
| Short-term Investments | Rs839.00 Million | Rs2.36 Billion | Rs1.06 Billion | Rs899.80 Million | Rs128.60 Million |
| Net Receivables | Rs1.17 Billion | Rs867.60 Million | Rs491.30 Million | Rs374.30 Million | Rs329.90 Million |
| Inventory | Rs1.24 Billion | Rs929.80 Million | Rs1.01 Billion | Rs950.50 Million | Rs829.90 Million |
| Property, Plant & Equipment | — | Rs1.65 Billion | Rs1.82 Billion | Rs1.16 Billion | Rs1.00 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Rs1.88 Billion | Rs1.27 Billion | Rs1.38 Billion | Rs1.12 Billion | Rs888.40 Million |
| Total Current Liabilities | Rs1.61 Billion | Rs1.20 Billion | Rs1.31 Billion | Rs1.03 Billion | Rs801.10 Million |
| Long-term Debt | Rs133.30 Million | — | — | Rs0.00 | Rs100.00K |
| Net Debt | Rs-1.72 Billion | Rs-1.40 Billion | Rs-197.20 Million | Rs-248.10 Million | Rs-560.00 Million |
| Total Stockholder Equity | Rs6.05 Billion | Rs5.31 Billion | Rs3.75 Billion | Rs3.08 Billion | Rs2.56 Billion |
| Retained Earnings | — | Rs4.74 Billion | Rs3.18 Billion | Rs2.51 Billion | Rs1.99 Billion |
RPG Life Sciences Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how RPG Life Sciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs652.80 Million | Rs778.60 Million | Rs943.60 Million | Rs908.20 Million | Rs647.50 Million |
| Capital Expenditures | Rs653.60 Million | Rs360.30 Million | Rs692.30 Million | Rs327.30 Million | Rs239.50 Million |
| Free Cash Flow | Rs-800.00K | Rs418.30 Million | Rs251.30 Million | Rs580.90 Million | Rs408.00 Million |
| Investing Cash Flow | Rs761.70 Million | Rs-418.00 Million | Rs-791.50 Million | Rs-1.06 Billion | Rs-346.60 Million |
| Financing Cash Flow | Rs-196.90 Million | Rs-270.80 Million | Rs-203.10 Million | Rs-171.20 Million | Rs-135.10 Million |
| Dividends Paid | Rs396.90 Million | Rs264.60 Million | Rs198.50 Million | Rs158.80 Million | Rs119.10 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs214.80 Million | Rs214.30 Million | Rs170.70 Million | Rs155.00 Million | Rs156.60 Million |
| Change in Cash | Rs1.62 Billion | Rs89.80 Million | Rs-51.00 Million | Rs-321.20 Million | Rs165.80 Million |
RPG Life Sciences Limited Earnings History — EPS Actual vs. Analyst Estimates
Track RPG Life Sciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 27, 2026 | — | — | — |
| Jan 22, 2026 | — | — | — |
| Nov 05, 2025 | — | — | — |
| Jul 18, 2025 | — | — | — |
| Apr 28, 2025 | — | — | — |
| Jan 30, 2025 | — | — | — |
| Oct 31, 2024 | — | — | — |
| Oct 30, 2020 | 6.74 | 5.68 | +18.66% |